Post by
stockfy on Jan 15, 2021 2:16pm
CZO: Double-digit revenue YoY growth in 2020 vs 2019
CZO's double-digit revenue YoY growth in 2020 is a sure thing and those who allege whatever else need to learn how to read an annual report. They also have to keep in mind that they do not talk to idiots when they post their clueless comments here.
CZO reported revenue YoY growth in 2019 versus 2018, facts below:
https://www.globenewswire.com/news-release/2020/04/16/2017361/0/en/Ceapro-Inc-Reports-Fourth-Quarter-and-Full-Year-2019-Results-and-Highlights.html
CZO also reported revenue YoY growth in the first nine months of 2020 compared with the first nine months of 2019, facts below:
https://www.globenewswire.com/news-release/2020/11/27/2135353/0/en/Ceapro-Inc-Reports-2020-Third-Quarter-and-Nine-Month-Financial-Results-and-Operational-Highlights.html
On top of this, CZO stated recently in its Q3 report that:
“Looking ahead, while taking into account the ongoing potential economic impact related to COVID-19 and evolving consumption trends, we believe Ceapro is well-positioned to once again deliver a double-digit growth in sales well in line with the positive trend achieved over the last years. With a strong balance sheet, a group of dedicated people, and a solid base business, coupled with the innovative technologies and products that we have developed to enable us to expand, Ceapro is poised to emerge as a successful life science company,” concluded Mr. Gagnon.
These are the facts from the company's reports although they do not help some investors' agenda.
Comment by
prophetoffacts on Jan 15, 2021 2:59pm
This post has been removed in accordance with Community Policy
Comment by
stockfy on Jan 17, 2021 3:01am
Excellent said. Accurate. Factual.
Comment by
Stocker46 on Jan 17, 2021 12:10pm
If I didn't know any better, I'd think Stockfy was another Digitel alias .. but he's appears to have been around for too long. The pumping is getting a little monotonous.